Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Effects of nalmefene on food intake and body weight of diet-induced obese mice

Aug. 3, 2004

Vaccination against ghrelin reduces food intake in mice

Aug. 3, 2004

Merck presents novel 11beta-HSD1 inhibitors for diabetes therapy

Aug. 3, 2004

New SGLT modulators identified at Aventis

Aug. 3, 2004

Forbes Medi-Tech adds cholesterol absorption inhibitors to pipeline

Aug. 2, 2004

New South African phase II study for Hemopure in trauma patients

Aug. 2, 2004

Novel MCH antagonists and their use in obesity and related disorders

Aug. 2, 2004

EstroGel becomes first available transdermal estrogen gel in U.S.

July 30, 2004

New PTP-1B inhibitors described by Wyeth researchers

July 30, 2004

New orexin-2 antagonists and their use in obesity and sleep disorders

July 30, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...